CİNSEL YOLLA BULAŞAN HASTALIKLARIN TARANMASI VE TEDAVİ PROTOKOLLERİNİN KARŞILAŞTIRILMASI

Öz

Kadınlarda vulvovajinal yakınmalar sağlık kuruluşlarına başvurma sebepleri arasında ilk sıralarda yer almaktadır.Vulvovajinal enfeksiyonlar, ayrıca  kadınlarda cinsel yolla bulaşan hastalıkların başvuru şikayetleri arasında da önemli bir yer tutmaktadır. Cinsel yolla bulaşan hastalıklar kadınlarda kalıcı üreme sağlığı problemlerine sebep olabilirler. Bu durum vulvovajinal enfeksiyon bulgularıyla sağlık kuruluşlarına gelen hasta popülasyonunda cinsel yolla bulaşan hastalıkların mutlaka ortaya çıkarılması konusundaki önemi göstermektedir. 

Günümüzde vulvovajinal enfeksiyon sebebi olan Kandida Albikans, Gardnarella Vajinalis, Trichomonas Vajinalis, N.Gonore ve Sifiliz gibi bakteriyel, parazitel yada mantarlara bağlı nedenler toplam vulvovajinal enfeksiyonların %80’ini oluşturmaktadır. Yapılan bu kesitsel araştırma ile indirekt yoldan Türkiye’deki cinsel yollardan bulaşan hastalıkların sıklığı ile ilgili bilgi sahibi olunması ve tedavi seçeneklerinin karşılaştırılması amaçlanmıştır.

Anahtar Kelimeler

• Cinsel yolla bulaşan hastalıklar,Jinekoloji,Vulvovajinal enfeksiyonlar,Çalışan kadın sağlığı,Üreme sağlığı

COMPARISON OF SCREENING AND TREATMENT PROTOCOLS OF SEXUALLY TRANSMITTED DISEASES

Öz

Vulvovaginal complaints are one of the top reasons for applying to medical institutions in women. Vulvovaginal infections also take an important place in chief complaints in sexually transmitted diseases in women. Sexually transmitted diseases can cause permanent reproductive health problems in women. This situation shows the importance of the fact that sexually transmitted diseases must be diagnosed in patient population who apply to medical institutions with vulvovaginal infection symptoms. Today bacterial, parasitic and fungal vulvovaginal infection causes like Candida Albicans, Gardnerella Vaginalis, Trichomonas Vaginalis, N. Gonorrhoeae, Syphilis make up 80% of the total vulvovaginal diseases. In this cross-sectional study, having information on the frequency of sexually transmitted diseases in Turkey indirectly and comparison of treatment options are aimed. 

Anahtar Kelimeler

• Sexual transmitted diseases,Gynecology,Vulvovaginal infections,Working woman’s health,Reproductive health

Kaynakça

1. Bakterial vaginosis: review of treatment options and potential clinical indications for therapy. Clinical Infectious Diseases. 20 Suppl l:S72-9, 1995 Apr.
2. Value of the score for Gram stains in the diagnosis of bacterial vaginosis. Pathologie Biologie. 42(5):539-43, 1994 May.
3. Diagnosis and prevalence of bacterial vaginosis. Journal of Postgraduate Medicine. 39(2):3, 1993 Apr-Jun.
4. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetrica et Gynecologica Scandinavica. 72(1):17-9, 1993 Jan.
5. Economical treatment of bacterial vaginosis. Japanese Journal of Antibiotics. 48(3):432-6, 1995 Mar.
6. Diagnosis of bacterial vaginosis in a routine diagnostic laboratory. Medical Laboratory Sciences. 49(1):8-11, 1992 Mar.
7. Risk factors for gonorrhea, syphilis and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourinary Medicine 70 (3):155-61, 1994 Jun.
8. A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis. Journal of Infectious Diseases. 170(1):242-6, 1994 Jul.

9. Jinekoloji polikliniğine başvuran kadınlarda Trichomonas vaginalis araştırılması. Mikrobiyoloji Bülteni. 27(4):357-63, 1993 Oct.
10. Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Dug Administration. Clinical Infectious Diseases. 15 Suppl 1:S115-22, 1992 Nov.
11. Treatment options for vulvovaginal candidiasis, 1993 Review. Clinical Infectious Diseases. 20 Suppl 1:S80-90, 1995 Apr.
12. Neotran - a new double - active pessary for the treatment of vaginitis. Journal of International Medical Research. 21(1): 36 -46, 1993 Jan - Feb
13. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis Obstetrics and Gynecology. 81(5(Pt l)): 721 - 7, 1993 May
14. The epidemiology of vulvovaginal candidiasis among university students. American Journal ofPublic Health. 85(8 Ptl):1146-8,1995 Aug.
15. Topical antifungal agents. Review Obstetrics and Gynecology Clinics of North America. 19(3):587- 607, 1992 Sep.
16. Blackwell AL, Fox AR, Phillips I, et al: Anaerobic vaginosis (nonspecific vaginosis): Clinical, microbiological and therapeutic findings. Lancet 2:1379-1382, 1982.
17. Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J Med 303:601 - 607, 1980.
18. Spiegel CA, Amsel R, Eschenbach DA, et al: Anaerobic bacteria in nonspecific vaginitis. N England J Med 303:601 - 607, 1980.
19. Holmes K.K, Chen KCS, Lipinski CM et al : Vaginal redox potential in bacterial vaginosis (nonspecific vaginitis). J Infect Dis 152:79-82, 1985
20. Holst E, Wathne B, Hovelius B, et al : Bacterial vaginosis: Microbiologic and clinical findings. Eur J Clin Microbiol 6: 536-541, 1987.
21. Paavonen J, Miettinen A, Stevens CE, et al: Mycoplasma Hominis in nonspecific vaginitis. Sex Transm Dis 10 (suppl): 271-275, 1983
22. Eschenbach DA, Hillier S, Critchlow C, et al: Diagnosis and clinical manifestation of bacterial vaginosis. Am J Obstet Gynecol 158:819-828, 1988
23. Pheifer TA, Forsyth PA, Durfee MA, et al: Nonspecific vaginitis: Role of Haemophilus vaginalis and treatment of metronidazole. N Engl J Med 298:14291434, 1978
24. Brand TM, Galask RP: Trimethylamine: The substance mainly responsible for the fishy odor often associated with bacterial vaginosis. Obstet Gynecol 68:682685, 1986
25. Chen KCS, Forsyth PS, Buchanan TM, et al: Amine content of vaginal fluid from untreated patients with nonspecific vaginitis. J Clin Invest 63:828-835, 1979
26. Spiegel CA, Amsel R, Holmes KK: Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol 18:170-177, 1983
27. Guys E: Sites of colonization of T. Vaginalis. Parazit 10:22, 1984
28. Fouts A, Kraus S: Trichomonas Vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 141: 137, 1980
29. Spence M: The clinical and laboratory diagnosis of T. vaginalis infection. Sex Transm Dis 7: 188, 1980
30. Senanayake P. Kramer DG: Contraception and the etiology of pelvic inflammatory disease: New perspectives. Am J Obstet Gynecol 138:852-860, 1980
31. Cramer DW, Schiff I, Schoenbaum SC, et al: Tubal infertility and the intrauterine device. N Engl J Med 312:941-949, 1985
32. Daling JR, Weiss NS, Metch BJ, et al : Primary tuba! infertility in relation to the use of an intrauterine device. N Engl J Med 312:937-945, 1985
33. Lee NC, Robin GL, Borucki R: The intrauterine device and pelvic inflamatory disease revisited: New results from the Women's Health Study. Obstet Gynecol 72:1,1988
34. Johns DR, i Tierney M, Felsenstein D: Alteration in the natural history of neurosyphillis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316: 1569, 1987
35. Lukehart SA, Hook EW, Baker- Zander SA, et al : In vasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 109: 855, 1988
36. Radolf JD, Kaplan RP: Unusual manifestation of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 18:432, 1988
37. Larsen SA, Hunter EF, Mc Grew BE: Syphilis. In Wentworth BB, Judson FN (eds):Laboratory Methods for the Diagnosis of Sexually Transmitted Diseases. Washington DC, American Public Health Association, 1984 p 1
38. Mascola L, Pelosi R, Alexander CE : Inadequate treatment of syphilis in pregnancy. Am J Obstet Gynecol 150:945, 1984
39. Philipson A, Sabath LD, Charles D: Transplacental passage of Erytromycin and Clindamycin. N Engl J Med 288: 1219, 1973